A case of successful combination treatment of a patient with myeloma and acute diverticulitis. Clinical observation

 Myeloma is an oncological disease characterized by uncontrolled formation of plasma cells in the bone marrow leading to destruction of bone tissue and accompanied by anemia and kidney failure. Morbidity is 1–2 % among all malignant tumors.
Specific antitumor therapy in conjunction with bone marrow transplant  allows to achieve satisfactory long-term outcomes. It should be noted that during therapy various complications are quite common, as well as  exacerbation of concomitant pathology which can transform into a competitive disease at any moment. A clinical observation of treatment of a  patient with myeloma and diverticulosis of the colon complicated by acute diverticulitis with paracolic infiltrate formation is presented. 

1. Bessmeltsev S.S. Multiple myeloma (pathogenesis, clinic, diagnosis, differential diagnosis). Part 1. Klinicheskaya onkogematologiya = Clinical Hematology 2013;6(3):237–57. (In Russ.).

2. Zueva E.E., Rusanova E.B., Slobodenuk K.Yu. et al. Multiple myeloma: modern trends in immunological monitoring. Effektivnaya farmakoterapiya = Effective pharmacotherapy 2011;(25):31–7. (In Russ.).

3. Mendeleeva L.P., Votyakova O.M., Pokrovskaya O.S. et al. National clinical guidelines for the diagnosis and treatment of multiple myeloma. Gematologiya i transfuziologiya = Hematology and Transfusiology 2016; 61(1-S2):1–24. (In Russ.). DOI: 10.18821/0234-5730-2016-61-1.

4. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Version 1.2022 – August 16, 2021. 5. Avet-Loiseau H., Attal M., Campion L. et al. Long-term analysis of the IFM 99 trials for myeloma: Cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining long-term survival. J Clin Oncol 2012;30(16):1949–52. DOI: 10.1200/JCO.2011.36.5726.

5. Harousseau J.-L., Dreyling M. et al. Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(Suppl 5): v155–7. DOI: 10.1093/annonc/mdq178.

6. Russian clinical guidelines for the diagnosis and treatment of lymphoproliferative diseases. Ed. by acad. I.V. Poddubnaya, acad. V.G. Savchenko. Moscow, 2018. (In Russ.).

7. National guidelines for the drug treatment of malignant tumors. Ed. By akad. A.D. Kaprin. M., 2020. (In Russ.).

8. Shelygin Yu.A., Achkasov S.I., Moskalev A.I. Classification of diverticular disease. Koloproktologiya = Coloproctology 2014;4(50):5–13. (In Russ.).

9. You H., Sweeny A., Cooper M. L. et al. The management of diverticulitis: a review of the guidelines. Med J Aust 2019;211(9):421–7. DOI:10.5694/mja2.50276.

10. Rezapour M., Stollman N. Antibiotics in Uncomplicated Acute Diverticulitis: To Give or Not to Give? Inflammatory Intest Dis 2018;3(2):75–9. DOI: 10.1159/000489631.

11. Bolkenstein H.E., van Dijk S.T., Consten E.C.J. et al. Conservative treatment in diverticulitis patients with pericolicextraluminal air and the role of antibiotic treatment. J Gastrointest Surg 2019;23(11):2269–76. DOI: 10.1007/s11605-019-04153-9.

12. Elagili F., Stocchi L., Ozuner G. et al. Antibiotics alone instead of percutaneous drainage as initial treatment of large diverticular abscess. Tech in Coloproctol 2015;19(2):97–103. DOI: 10.1007/s10151-014-1250-9.

13. Gregersen R., Mortensen L.Q., Burcharth J. et al. Treatment of patients with acute colonic diverticulitis complicated by abscess formation: A systematic review. Int J Surg 2016;35:201–8. DOI:10.1016/j.ijsu.2016.10.006.